These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21616187)

  • 1. MicroRNA-like antivirals.
    Arbuthnot P
    Biochim Biophys Acta; 2011; 1809(11-12):746-55. PubMed ID: 21616187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAs.
    Dyer V; Ely A; Bloom K; Weinberg M; Arbuthnot P
    Biochem Biophys Res Commun; 2010 Aug; 398(4):640-6. PubMed ID: 20599752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.
    Mowa MB; Crowther C; Ely A; Arbuthnot P
    Microrna; 2012; 1(1):19-25. PubMed ID: 25048086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA cassettes in viral vectors: problems and solutions.
    Liu YP; Berkhout B
    Biochim Biophys Acta; 2011; 1809(11-12):732-45. PubMed ID: 21679781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.
    Ely A; Naidoo T; Mufamadi S; Crowther C; Arbuthnot P
    Mol Ther; 2008 Jun; 16(6):1105-12. PubMed ID: 18431360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X; Haurigot V; Zhou S; Luo G; Couto LB
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing RNA interference for the treatment of viral infections.
    Arbuthnot P
    Drug News Perspect; 2010; 23(6):341-50. PubMed ID: 20697601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.
    Herrera-Carrillo E; Liu YP; Berkhout B
    Hum Gene Ther Methods; 2017 Aug; 28(4):177-190. PubMed ID: 28712309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
    Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors.
    van den Berg FT; Ely A; Arbuthnot P
    Methods Mol Biol; 2020; 2115():185-197. PubMed ID: 32006402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.
    Chattopadhyay S; Ely A; Bloom K; Weinberg MS; Arbuthnot P
    Biochem Biophys Res Commun; 2009 Nov; 389(3):484-9. PubMed ID: 19733548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters.
    Lo HL; Chang T; Yam P; Marcovecchio PM; Li S; Zaia JA; Yee JK
    Gene Ther; 2007 Nov; 14(21):1503-12. PubMed ID: 17805304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference inhibitors of hepatitis B virus.
    McCaffrey AP
    Ann N Y Acad Sci; 2009 Sep; 1175():15-23. PubMed ID: 19796073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat.
    Barichievy S; Saayman S; von Eije KJ; Morris KV; Arbuthnot P; Weinberg MS
    Oligonucleotides; 2007; 17(4):419-31. PubMed ID: 17896874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA, miRNA and HIV: promises and challenges.
    Yeung ML; Bennasser Y; LE SY; Jeang KT
    Cell Res; 2005; 15(11-12):935-46. PubMed ID: 16354572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
    Bourhill T; Arbuthnot P; Ely A
    J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response.
    Dang LT; Kondo H; Aoki T; Hirono I
    Antiviral Res; 2008 Dec; 80(3):316-23. PubMed ID: 18687362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgene-like animal models using intronic microRNAs.
    Lin SL; Chang SJ; Ying SY
    Methods Mol Biol; 2006; 342():321-34. PubMed ID: 16957386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.